GCG and diabetes mellitus: Patients with CVD were more likely to have almost all diabetes complications of micro-vascular disease, and more likely to use statins, renin angiotensin system inhibitors and antidiabetes drugs including oral antidiabetes drugs (OADs), glucagon-like peptide-1(GLP-1) based drugs and insulin than those without CVD (Table 1).